Maintenance of rituximab treatment in a patient with primary Sjögren's syndrome.
Internal Medicine VI, Department of Internal Medicine, Department of Radiology II and Department for Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
Georg Franz
GF
Lehner
Internal Medicine VI, Department of Internal Medicine, Department of Radiology II and Department for Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
Malgorzata
M
Brunner-Palka
Internal Medicine VI, Department of Internal Medicine, Department of Radiology II and Department for Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
Thomas
T
Rettenbacher
Internal Medicine VI, Department of Internal Medicine, Department of Radiology II and Department for Ophthalmology, Medical University Innsbruck, Innsbruck, Austria.
Regina
R
Schmidauer
Internal Medicine VI, Department of Internal Medicine, Department of Radiology II and Department for Ophthalmology, Medical University Innsbruck, Innsbruck, Austria. manfred.herold@i-med.ac.at.
Manfred
M
Herold
D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab